J Rheum Dis.  2017 Jun;24(3):131-137. 10.4078/jrd.2017.24.3.131.

Differential Diagnosis of Juvenile Idiopathic Arthritis

Affiliations
  • 1Department of Pediatrics, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea. kmsc29@hanmail.net
  • 2Department of Orthopaedic Surgery, Albert Einstein College of Medicine, New York, USA.
  • 3Department of Orthopaedic Surgery, Montefiore Medical Center, New York, USA.

Abstract

Juvenile idiopathic arthritis (JIA) is a broad spectrum of disease defined by the presence of arthritis of unknown etiology, lasting more than six weeks duration, and occurring in children less than 16 years of age. JIA encompasses several disease categories, each with distinct clinical manifestations, laboratory findings, genetic backgrounds, and pathogenesis. JIA is classified into seven subtypes by the International League of Associations for Rheumatology: systemic, oligoarticular, polyarticular with and without rheumatoid factor, enthesitis-related arthritis, psoriatic arthritis, and undifferentiated arthritis. Diagnosis of the precise subtype is an important requirement for management and research. JIA is a common chronic rheumatic disease in children and is an important cause of acute and chronic disability. Arthritis or arthritis-like symptoms may be present in many other conditions. Therefore, it is important to consider differential diagnoses for JIA that include infections, other connective tissue diseases, and malignancies. Leukemia and septic arthritis are the most important diseases that can be mistaken for JIA. The aim of this review is to provide a summary of the subtypes and differential diagnoses of JIA.

Keyword

Juvenile idiopathic arthritis; Subtype; Differential diagnosis; Children

MeSH Terms

Arthritis
Arthritis, Infectious
Arthritis, Juvenile*
Arthritis, Psoriatic
Child
Connective Tissue Diseases
Diagnosis
Diagnosis, Differential*
Genetic Background
Humans
Leukemia
Rheumatic Diseases
Rheumatoid Factor
Rheumatology
Rheumatoid Factor

Reference

1. Cassidy JT, Petty RE, Laxer RM, Lidsley CB. Textbook of pediatric rheumatology. 6th ed.Philadelphia: Saunders Co;2010. p. 211–97.
2. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369:767–78.
Article
3. Still GF. On a form of chronic joint disease in children. 1896. Clin Orthop Relat Res. 1990; (259):4–10.
4. Kim KH, Kim DS. Juvenile idiopathic arthritis: Diagnosis and differential diagnosis. Korean J Pediatr. 2010; 53:931–5.
Article
5. Kim KN. Chronic arthritis in childhood. J Rheum Dis. 2012; 19:307–15.
Article
6. Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014; 81:112–7.
Article
7. Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016; 3:187–207.
Article
8. Fujikawa S, Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn. 1997; 39:245–9.
Article
9. Martini A. Systemic juvenile idiopathic arthritis. Autoimmun Rev. 2012; 12:56–9.
Article
10. Duffy CM, Colbert RA, Laxer RM, Schanberg LE, Bowyer SL. Nomenclature and classification in chronic childhood arthritis: time for a change? Arthritis Rheum. 2005; 52:382–5.
Article
11. Ravelli A, Minoia F, Davì S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016; 75:481–9.
12. Ansell BM. Juvenile chronic arthritis. Scand J Rheumatol Suppl. 1987; 66:47–50.
Article
13. Al-Matar MJ, Petty RE, Tucker LB, Malleson PN, Schroeder ML, Cabral DA. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheum. 2002; 46:2708–15.
Article
14. Felici E, Novarini C, Magni-Manzoni S, Pistorio A, Magnani A, Bozzola E, et al. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. J Rheumatol. 2005; 32:1805–10.
15. Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol. 2003; 135:879–84.
16. Rosenberg AM. Uveitis associated with childhood rheumatic diseases. Curr Opin Rheumatol. 2002; 14:542–7.
Article
17. Hu-Torres S, Foster CS. Disease of the year: juvenile idiopathic arthritis–differential diagnosis. Ocul Immunol Inflamm. 2014; 22:42–55.
Article
18. Szer IS, Kimura Y, Malleson PN, Southwood TR. Arthritis in children and adolescents. New York: Oxford University Press;2006. p. 104–212.
19. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31:390–2.
20. Jadon DR, Ramanan AV, Sengupta R. Juvenile versus adult-onset ankylosing spondylitis – clinical, radiographic, and social outcomes. a systematic review. J Rheumatol. 2013; 40:1797–805.
Article
21. Ravelli A, Consolaro A, Schiappapietra B, Martini A. The conundrum of juvenile psoriatic arthritis. Clin Exp Rheumatol. 2015; 33(5 Suppl 93):S40–3.
22. Burgos-Vargas R, Rudwaleit M, Sieper J. The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol. 2002; 29:869–74.
23. Tsitsami E, Bozzola E, Magni-Manzoni S, Viola S, Pistorio A, Ruperto N, et al. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. Arthritis Rheum. 2003; 49:488–93.
Article
24. Stoll ML, Cron RQ. Treatment of juvenile idiopathic arthritis: a revolution in care. Pediatr Rheumatol Online J. 2014; 12:13.
Article
25. Brown DC. Arthralgia in children. Can Fam Physician. 1983; 29:2149–51.
26. Aupiais C, Ilharreborde B, Doit C, Blachier A, Desmarest M, Job-Deslandre C, et al. Aetiology of arthritis in hospitalised children: an observational study. Arch Dis Child. 2015; 100:742–7.
Article
27. Prabhu AS, Balan S. Approach to a child with monoarthritis. Indian J Pediatr. 2010; 77:997–1004.
Article
28. Singh S, Mehra S. Approach to polyarthritis. Indian J Pediatr. 2010; 77:1005–10.
Article
29. Aupiais C, Basmaci R, Ilharreborde B, Blachier A, Desmarest M, Job-Deslandre C, et al. Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis. Arch Dis Child. 2016 Sep 21; [Epub].DOI: DOI: 10.1136/archdischild-2016-310594.
Article
30. Krogstad P. Septic arthritis. Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 7th ed.Philadelphia: Elsevier Saunders;2014. p. 727.
Article
31. Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013; 65:2499–512.
32. Ravelli A, Martini A. Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2003; 21(5 Suppl 31):S89–93.
33. Cassidy JT, Petty RE, Laxer RM, Lidsley CB. Textbook of pediatric rheumatology. 6th ed.Philadelphia: Saunders Co;2010. p. 575.
34. Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. J Pediatr. 1999; 134:53–7.
Article
35. Gurcay E, Eksioglu E, Ezer U, Tuncay R, Cakci A. Functional disability in children with hemophilic arthropathy. Rheumatol Int. 2006; 26:1031–5.
Article
36. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110:2747–71.
Article
Full Text Links
  • JRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr